‘Buying stuff like it’s going out of fashion’: Biotech M&A on track for best year since pre-Covid
Story summaryGlobal biopharma M&A is experiencing a sharp uptick, putting the sector on track for its strongest year since the pre-pandemic peak seven years ago.
Read at CNBCOpens the original publisher in a new tab. Full articles belong to their publishers; a subscription may be required.